Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.02.19
Views: 1731
Rating:

Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK

Dr Yee Pei Song speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about the BCON study looking at longterm outcomes of hypoxia modification in bladder preservation.

She reports that hypoxia modification resulted in a sustained benefit with overall survival in 5 years continuing to improve.

She explains that this treatment is good and continues to benefit patients and when compared to cytotoxics it has a different side effect profile and is well tolerated.
 

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation